Feedback / Questions
ontunisertib (AGMB-129) - AgomAb Therapeutics
https://www.globenewswire.com/news-release/2026/08/06/3340677/0/en/agomab-reports-half-year-2026-financial-results-and-confirms-2026-outlook.html
Aug 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next